Viewing Study NCT00475293


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-01-03 @ 6:38 AM
Study NCT ID: NCT00475293
Status: COMPLETED
Last Update Posted: 2013-09-13
First Post: 2007-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module